Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

American Health Packaging Rifampin Capsules Recalled for Impurity Issues

Agency Publication Date: January 30, 2024
Share:
Sign in to monitor this recall

Summary

Amerisource Health Services LLC is recalling 1,568 cartons of Rifampin Capsules USP (150 mg), which were distributed by American Health Packaging. This recall was initiated because the medication failed to meet required specifications for impurities and degradation. Rifampin is an antibiotic used to treat tuberculosis and certain other bacterial infections; no incidents or injuries have been reported to date.

Risk

Taking medication that has degraded or contains impurities may lead to reduced effectiveness of the treatment or potential side effects from breakdown products. For patients treating serious infections like tuberculosis, a sub-therapeutic dose can lead to treatment failure or the development of antibiotic resistance.

What You Should Do

  1. The recalled products are Rifampin Capsules USP, 150 mg, sold in 30-capsule unit-dose cartons (NDC 60687-575-21) and unit doses (NDC 60687-575-11).
  2. Check your medication packaging for Lot number 1008111 with an expiration date of 01/31/2024.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Rifampin Capsules USP, 150 mg (30 Capsules)
Variants: 150 mg, 30 Capsules (3 x 10) unit doses per carton
Lot Numbers:
1008111 (Exp 01/31/2024)
NDC:
60687-575-21
60687-575-11

Rx Only. Distributed by: American Health Packaging, Columbus, Ohio 43217.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 93851
Status: Resolved
Manufacturer: Amerisource Health Services LLC
Sold By: Pharmacies; American Health Packaging
Manufactured In: United States
Units Affected: 1,568 cartons
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.